Teladoc Health Inc (NYSE:TDOC), a company specializing in virtual healthcare services, recently witnessed a significant transaction by one of its top executives. Stephany Verstraete, Chief Marketing Officer, sold 15,000 shares of the company on August 7, 2024. The transaction was documented in an SEC filing. Following this sale, the insider now owns 45,158 shares of Teladoc Health Inc.

Over the past year, the insider has sold a total of 18,111 shares and purchased no shares. This recent sale is part of a broader trend at Teladoc Health Inc., where there were 73 insider sales and only 1 insider purchase over the past year.

On the day of the sale, Teladoc Health Inc. shares were trading at $7.6. This price values ​​the company at a market capitalization of around $1.234 billion. According to GF Value, an intrinsic value estimate calculated by GuruFocus, the stock has a GF Value of $28.01. This results in a Price to GF Value ratio of 0.27, which suggests that the stock could be a potential value trap and investors should think twice before investing.

The GF value is determined based on historical multiples such as price-earnings ratio, price-sales ratio, price-book ratio and price-free cash flow and adjusted by a GuruFocus factor that takes into account past earnings and growth as well as analysts’ estimates of future business development.

Teladoc Health Inc offers a range of healthcare services through a virtual platform that enables remote doctor visits and medical consultations. This service model has become increasingly important in the current healthcare landscape, emphasizing convenience and accessibility.

This article created by GuruFocus is intended to provide general insights and does not constitute tailored financial advice. Our commentary is based on historical data and analyst forecasts, uses an unbiased methodology and is not intended to serve as specific investment advice. It does not contain a recommendation to buy or sell any stock and does not take into account any individual investment objectives or financial circumstances. Our goal is to provide long-term, fundamental, data-driven analysis. Note that our analysis may not include the most recent, price-sensitive company announcements or qualitative information. GuruFocus does not hold a position in any stocks mentioned here.

This article first appeared on GuruFocus.